Fusion Pharmaceuticals Ownership | Who Owns Fusion Pharmaceuticals?
Fusion Pharmaceuticals Ownership Summary
Fusion Pharmaceuticals is owned by 94.52% institutional investors, and 5.48% retail investors. First trust capital management is the largest institutional shareholder, holding 0% of FUSN shares. Federated Hermes Kaufmann R is the top mutual fund, with 6.44% of its assets in Fusion Pharmaceuticals shares.
FUSN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Fusion Pharmaceuticals | 94.52% | - | 5.48% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
First trust capital management | - | - | - |
Geode capital management | - | - | - |
Voya investment management | - | - | - |
Proshare advisors | - | - | - |
Pentwater capital management lp | - | - | - |
Yakira capital management | - | - | - |
Atika capital management | - | - | - |
Legal & general group | - | - | - |
Toth financial advisory | - | - | - |
Gabelli funds | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
First trust capital management | - | - | - |
Geode capital management | - | - | - |
Voya investment management | - | - | - |
Proshare advisors | - | - | - |
Pentwater capital management lp | - | - | - |
Yakira capital management | - | - | - |
Atika capital management | - | - | - |
Legal & general group | - | - | - |
Toth financial advisory | - | - | - |
Gabelli funds | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Scarborough advisors | - | - | -13.00 |
Gamma investing | - | - | -26.00 |
Fny investment advisers | - | - | -85.00 |
Advisor group | - | - | -86.00 |
Daiwa securities group | - | - | -268.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Federated hermes | - | - | -10.81M |
Perceptive advisors | - | - | -6.83M |
Avidity partners management lp | - | - | -6.50M |
Deerfield management company, l.p. (series c) | - | - | -6.40M |
Fil | - | - | -4.19M |
Sold Out
Holder | Change |
---|---|
Scarborough advisors | -13.00 |
Gamma investing | -26.00 |
Fny investment advisers | -85.00 |
Advisor group | -86.00 |
Daiwa securities group | -268.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2024 | 140 | 68.67% | 69,088,929 | 13.64% | 94 | 1.22% | 95 | 66.67% | 13 | 62.50% |
Dec 31, 2023 | 83 | 112.82% | 60,795,560 | 21.84% | 88 | 1.55% | 57 | 375.00% | 8 | - |
Sep 30, 2023 | 39 | -2.50% | 49,899,434 | -0.71% | 75 | 0.86% | 12 | -25.00% | 8 | 60.00% |
Jun 30, 2023 | 40 | 11.11% | 50,257,178 | 10.27% | 93 | 1.30% | 16 | -11.11% | 5 | 25.00% |
Mar 31, 2023 | 36 | 20.00% | 45,577,701 | 60.64% | 84 | 2.11% | 18 | 125.00% | 4 | 33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Federated Hermes Kaufmann R | 5.48M | 6.44% | - |
Federated Hermes Kaufmann Growth | 5.48M | 6.44% | - |
Federated Hermes Kaufmann Small Cap Grow | 5.07M | 5.97% | - |
Federated Hermes Kaufmann Small Cap A | 5.07M | 5.97% | - |
Fidelity Canadian Large Cap Sr B | 2.55M | 3.00% | 2.55M |
Fidelity Canadian Large Cp Mlt Ast Bs O | 1.74M | 2.05% | 80.00K |
Fidelity Concntr Val Priv Pool Sr F | 479.45K | 0.56% | 479.45K |
Fidelity Monthly Income Series F | 418.71K | 0.49% | 418.71K |
Fidelity Global Equity+ Fund - F | 381.14K | 0.45% | 221.25K |
MEDICAL BioHealth EUR Acc | 308.00K | 0.36% | 308.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
2023 Q3 | - | - |
2023 Q2 | - | - |
FUSN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools